According to Athersys's latest financial reports the company's total liabilities are $43.82 M. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2022-12-31 | $51.58 M | 17.73% |
2021-12-31 | $43.81 M | 54.54% |
2020-12-31 | $28.35 M | 54.13% |
2019-12-31 | $18.39 M | -1.18% |
2018-12-31 | $18.61 M | 82.19% |
2017-12-31 | $10.21 M | 29.67% |
2016-12-31 | $7.87 M | 45.77% |
2015-12-31 | $5.4 M | -30.91% |
2014-12-31 | $7.82 M | -45.55% |
2013-12-31 | $14.36 M | 95.31% |
2012-12-31 | $7.35 M | -12.46% |
2011-12-31 | $8.4 M | -16.81% |
2010-12-31 | $10.1 M | 7.76% |
2009-12-31 | $9.37 M | 305.1% |
2008-12-31 | $2.31 M | -49.63% |
2007-12-31 | $4.59 M | 898921.53% |
2006-12-31 | $0 M | |
2005-12-31 | $N/A | |
2004-12-31 | $N/A | -100% |
2003-12-31 | $15.55 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $98.78 B | 225,315.88% | ๐บ๐ธ USA |
Pfizer PFE | $137.21 B | 313,007.27% | ๐บ๐ธ USA |
Amgen AMGN | $90.92 B | 207,375.53% | ๐บ๐ธ USA |
Sanofi SNY | $57.61 B | 131,367.49% | ๐ซ๐ท France |
Merck MRK | $69.04 B | 157,442.84% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $65.67 B | 149,761.94% | ๐บ๐ธ USA |
Moderna
MRNA | $4.57 B | 10,332.88% | ๐บ๐ธ USA |